Bone Therapeutics

Shareholders Meeting


Annual General Meeting 26 May 2017

Notice: EN - FR

Proxy: EN - FR

Shareholders' rights pursuant to art. 553ter and 540 of the Belgian Companies Code: EN - FR

Report of the Board of Directors on the consolidated and statutory annual accounts, including the Auditor's report on the consolidated annual accounts: EN - FR

Auditor's report on the statutory annual accounts for the period ended 31 December 2016: FR

Statutory annual accounts: FR

CV new directors:

Thomas Lienard: EN
Damian Marron: EN
Steven Swinson: EN